View Document Preview and Link Document Date: 2014-07-03 18:13:15 Open Document File Size: 1,91 MB Share Result on Facebook
City Seattle / / Company Novartis / BVGH BIO Ventures / BIO Ventures / Sanofi / ETEC / / Continent Europe / / Country Myanmar / Mexico / Pakistan / United States / China / India / / Currency USD / EUR / / Event Product Issues / Funding / FDA Phase / / / IndustryTerm appropriate health technologies / biotechnology / revised product / biotechnology-based drugs / treatment of diarrhea / contaminated food / pharmaceutical / gross domestic product / oral rehydration solution / actual product / pharmaceutical/ biotechnology / travel market penetration / / MedicalCondition just reducing illness / diarrheal diseases / considerable physical suffering / ETEC disease / acute illness / acute and chronic medical costs / nausea / dysentery / inactivated whole-cell cholera / travelers’ diarrhea / common illness / Diarrhea / enteric fever / illness / diarrheal disease / diarrheal illness / malnutrition / severe dehydration / chronic functional gastrointestinal disorders / enteric illness / acute diarrhea / disease / common infectious disease / functional gastrointestinal disorders / severe diarrhea / post-deployment chronic sequelae / dangerous dehydration / several candidate cholera / functional gastrointestinal disorder / fever / typhoid / typhoid vaccines / cholera / reactive arthritis / typhoid vaccines29 / irritable bowel syndrome / dehydration / / MedicalTreatment Immunization / vaccination / ORT / oral rehydration / oral rehydration therapy / / Organization World Health Organization / North Atlantic Treaty Organization / Melinda Gates Foundation / Research Council of Norway / 13 / BIO Ventures for Global Health / United Kingdom’s Department for International Development / 12 / PATH / GAVI Alliance / European Union / Global Health / / Person Mike Wang / Wendy Stone / / / Position Executive / Contents Executive / / Product ETEC vaccine / drinking water / food / / ProvinceOrState Washington / / Technology biotechnology / appropriate health technologies / / URL www.path.org / www.bvgh.org / / SocialTag 
The Case for Investment in Enterotoxigenic Escherichia coli Vaccines March 2011 PATH is an international, nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to